Orgenesis: CORRECTION: Orgenesis Q2 EPS Loss Of $(0.23) ...
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!
Read full article »
Orgenesis is a Maryland-based biotechnology company that researches and develops cell and gene therapies for the treatment of a wide range of diseases.
Read more